Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02138786
Title Study of Selinexor (KPT-330) in Patients With Refractory and/or Relapsed Richter's Transformation (RT)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Karyopharm Therapeutics, Inc
Indications

diffuse large B-cell lymphoma

Therapies

Selinexor

Age Groups: adult
Covered Countries USA | ESP | DEU


No variant requirements are available.